Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Leukemia Research Reports|September 11, 2023
Waldenstrom's macroglobulinemia-like B cell lymphoma with MYD88 L265P mutation and t(14;18)(q32;q21) involving IGH-MALT1Rie Furuta, Hiro Tatetsu, Jun-Ichirou Yasunaga, et al.International Journal of Clinical Oncology|September 19, 2024
Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancerHiroki Inada, Hideaki Miyamoto, Satoru Shinriki, et al.International Journal of Hematology|November 29, 2014
Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective studyYoshitaka Kikukawa, Hiromichi Yuki, Sinya Hirata, et al.Scientific Reports|June 3, 2016
Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibodyKenji Sugata, Jun-Ichirou Yasunaga, Michi Miura, et al.Cureus|January 4, 2024
A Rare Case of Adult Poorly Differentiated Chordoma of the Skull Base With Rapid Progression and Systemic Metastasis: A Review of the LiteratureKeisuke Harada, Naoki Shinojima, Haruaki Yamamoto, et al.Cancer Science|June 23, 2021
Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in JapanKoji Izutsu, Kiyoshi Ando, Momoko Nishikori, et al.Journal of Clinical and Experimental Hematopathology : JCEH|December 14, 2018
Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphomaYoshihiro Komohara, Osamu Noyori, Yoichi Saito, et al.Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genomeYorifumi Satou, Paola Miyazato, Ko Ishihara, et al.International Journal of Hematology|August 23, 2024
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II studyKoji Izutsu, Kiyoshi Ando, Momoko Nishikori, et al.Clinical & Translational Immunology|August 17, 2019
Expression of IL-34 correlates with macrophage infiltration and prognosis of diffuse large B-cell lymphomaOsamu Noyori, Yoshihiro Komohara, Hesham Nasser, et al.Pageof 10